Literature DB >> 21695389

Hypothalamic control of energy and glucose metabolism.

Stephanie Sisley1, Darleen Sandoval.   

Abstract

The central nervous system (CNS), generally accepted to regulate energy homeostasis, has been implicated in the metabolic perturbations that either cause or are associated with obesity. Normally, the CNS receives hormonal, metabolic, and neuronal input to assure adequate energy levels and maintain stable energy homeostasis. Recent evidence also supports that the CNS uses these same inputs to regulate glucose homeostasis and this aspect of CNS regulation also becomes impaired in the face of dietary-induced obesity. This review focuses on the literature surrounding hypothalamic regulation of energy and glucose homeostasis and discusses how dysregulation of this system may contribute to obesity and T2DM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21695389     DOI: 10.1007/s11154-011-9189-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  183 in total

1.  Central administration of oleic acid inhibits glucose production and food intake.

Authors:  Silvana Obici; Zhaohui Feng; Kimyata Morgan; Daniel Stein; George Karkanias; Luciano Rossetti
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

2.  Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats.

Authors:  Gregory J Morton; Kevin D Niswender; Christopher J Rhodes; Martin G Myers; James E Blevins; Denis G Baskin; Michael W Schwartz
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

Review 3.  How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.

Authors:  S Rivest; S Lacroix; L Vallières; S Nadeau; J Zhang; N Laflamme
Journal:  Proc Soc Exp Biol Med       Date:  2000-01

4.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin.

Authors:  M W Schwartz; A J Sipols; J L Marks; G Sanacora; J D White; A Scheurink; S E Kahn; D G Baskin; S C Woods; D P Figlewicz
Journal:  Endocrinology       Date:  1992-06       Impact factor: 4.736

5.  Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain.

Authors:  V K Han; M A Hynes; C Jin; A C Towle; J M Lauder; P K Lund
Journal:  J Neurosci Res       Date:  1986       Impact factor: 4.164

6.  Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.

Authors:  A S Rocca; P L Brubaker
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

7.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

Authors:  L A Scrocchi; T J Brown; N MaClusky; P L Brubaker; A B Auerbach; A L Joyner; D J Drucker
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

8.  Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats.

Authors:  M W Schwartz; J L Marks; A J Sipols; D G Baskin; S C Woods; S E Kahn; D Porte
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

9.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Authors:  A Christine Könner; Ruth Janoschek; Leona Plum; Sabine D Jordan; Eva Rother; Xiaosong Ma; Chun Xu; Pablo Enriori; Brigitte Hampel; Gregory S Barsh; C Ronald Kahn; Michael A Cowley; Frances M Ashcroft; Jens C Brüning
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

10.  Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance.

Authors:  Paulo J F Martins; Michael Haas; Silvana Obici
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

View more
  17 in total

Review 1.  Brain GLP-1 and insulin sensitivity.

Authors:  Darleen Sandoval; Stephanie R Sisley
Journal:  Mol Cell Endocrinol       Date:  2015-02-24       Impact factor: 4.102

2.  S-resistin, a non secretable resistin isoform, impairs the insulin signalling pathway in 3T3-L1 adipocytes.

Authors:  María Rodríguez; Eduardo Moltó; Lidia Aguado; Nilda Gallardo; Antonio Andrés; Carmen Arribas
Journal:  J Physiol Biochem       Date:  2015-06-04       Impact factor: 4.158

Review 3.  Can Brown Fat Win the Battle Against White Fat?

Authors:  Sawsan Elattar; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

4.  A potential role for the midbrain in integrating fat-free mass determined energy needs: An H2 (15) O PET study.

Authors:  Christopher M Weise; Pradeep Thiyyagura; Eric M Reiman; Kewei Chen; Jonathan Krakoff
Journal:  Hum Brain Mapp       Date:  2015-03-13       Impact factor: 5.038

5.  GRP78 overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice.

Authors:  T Teodoro-Morrison; I Schuiki; L Zhang; D D Belsham; A Volchuk
Journal:  Diabetologia       Date:  2013-03-09       Impact factor: 10.122

Review 6.  Interactions between the central nervous system and pancreatic islet secretions: a historical perspective.

Authors:  Denovan P Begg; Stephen C Woods
Journal:  Adv Physiol Educ       Date:  2013-03       Impact factor: 2.288

7.  Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity.

Authors:  Marc Schneeberger; Jordi Altirriba; Ainhoa García; Yaiza Esteban; Carlos Castaño; Montserrat García-Lavandeira; Clara V Alvarez; Ramon Gomis; Marc Claret
Journal:  Mol Metab       Date:  2012-11-12       Impact factor: 7.422

8.  Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.

Authors:  Stephanie Sisley; Kathleen Smith; Darleen A Sandoval; Randy J Seeley
Journal:  Peptides       Date:  2014-05-29       Impact factor: 3.750

9.  Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance.

Authors:  Marc Schneeberger; Marcelo O Dietrich; David Sebastián; Mónica Imbernón; Carlos Castaño; Ainhoa Garcia; Yaiza Esteban; Alba Gonzalez-Franquesa; Ignacio Castrillón Rodríguez; Analía Bortolozzi; Pablo M Garcia-Roves; Ramon Gomis; Ruben Nogueiras; Tamas L Horvath; Antonio Zorzano; Marc Claret
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

10.  Increasing muscle mass to improve metabolism.

Authors:  Alexandra C McPherron; Tingqing Guo; Nichole D Bond; Oksana Gavrilova
Journal:  Adipocyte       Date:  2013-04-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.